Manufacturer
Exelixis
Pharmaceutical manufacturer based in United States
United States
- Products listed
- 5
- Molecules
- 2
- Therapy areas
- 1
Exelixis is a pharmaceutical manufacturer based in United States. MedsAcross lists 5 of its products across 2 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- United States
- Indian manufacturer
- No
- Also listed as
- Exelixis, Inc.
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Exelixis products through licensed channels, with the documents your regulator needs.
Oncology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Cometriq kit | Cabozantinib | US FDA | Available on request |
Other products
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Cabometyx 20 mg tabletOral | Cabozantinib s-malate | US FDA | Available on request |
| Cabometyx 40 mg tabletOral | Cabozantinib s-malate | US FDA | Available on request |
| Cabometyx 60 mg tabletOral | Cabozantinib s-malate | US FDA | Available on request |
| Cometriq 20 mg capsuleOral | Cabozantinib s-malate | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Exelixis
Send a request for any of these products. We confirm the licensed source, documents and lead time.